MARKET

MOTS

MOTS

Motus Gi Hldgs Inc
NASDAQ
0.4161
-0.0186
-4.28%
After Hours: 0.4410 +0.0249 +5.98% 18:34 03/27 EDT
OPEN
0.4530
PREV CLOSE
0.4347
HIGH
0.4530
LOW
0.4100
VOLUME
69.97K
TURNOVER
0
52 WEEK HIGH
23.40
52 WEEK LOW
0.4011
MARKET CAP
2.09M
P/E (TTM)
-0.0262
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at MOTS last week (0318-0322)?
Weekly Report · 3d ago
Motus GI Holdings files to sell 4.4M common shares for holders
Motus GI Holdings files to sell 4.4M common shares for holders Mar. 22, 2024. The company filed a prospectus related to the proposed resale of ~4.4m common shares by the selling stockholders. This prospectus is not an offer to sell these securities.
Seeking Alpha · 5d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Ontrak (NASDAQ:OTRK) shares rose 173.2% to $0.52 during Tuesday's pre-market session. Fusion Pharmaceuticals and Enveric Biosciences moved upwards by 97.46% and 39.09% respectively. Losers include Seelos Therapeutics and Acurx Pharmaceuticals.
Benzinga · 03/19 13:05
MOTS Stock Earnings: Motus GI Hldgs Misses EPS, Misses Revenue for Q4 2023
Motus GI Hldgs just reported results for the fourth quarter of 2023. The company reported earnings per share of -$4.48 and revenue of $64,000. This was 68% worse than the analyst estimate for the company to report revenue of
Investorplace · 03/19 02:53
Motus GI GAAP EPS of -$4.48 misses by $0.29, revenue of $0.06M misses by $0.14M
Seeking Alpha · 03/18 20:44
Motus Gi Holdings Unveils Informal Financial Update
TipRanks · 03/18 20:25
Motus GI Hldgs Q4 EPS $(4.48) Misses $(4.39) Estimate, Sales $64.00K Miss $150.00K Estimate
Motus GI Hldgs reported quarterly losses of $4.48 per share. The company reported quarterly sales of $64.00 thousand which missed the analyst consensus estimate by 57.33 percent. Motus GI also missed the quarterly sales estimate for the same period last year.
Benzinga · 03/18 20:08
*Motus GI Holdings: Engaged in the Process to Seek Strategic Partnerships Aimed at Accelerating Commercialization of the Pure-Vu System and Maximizing Stockholder Value >MOTS
Dow Jones · 03/18 20:07
More
About MOTS
Motus GI Holdings, Inc. is a medical technology company. It has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation. The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles.

Webull offers Motus GI Holdings Inc stock information, including NASDAQ: MOTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MOTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MOTS stock methods without spending real money on the virtual paper trading platform.